According to the duty to warn:

Question

BlackTom AI · Accepted Answer

The learned intermediary doctrine holds that a manufacturer of prescription drugs or medical devices can satisfy its duty to warn by informing the prescribing physician (the “learned intermediary”) of known risks, because the physician is positioned to evaluate risks and advise the patient.

1) Relevant knowledge points and concepts
- Duty to warn: manufacturers must provide adequate warnings about product risks to foreseeable users. In the medical context this duty is often fulfilled by warning the prescribing physician rather than the patient directly.  
- Learned intermediary doctrine: legal principle in products liability that places the responsibility on manufacturers to warn prescribing clinicians who then communicate risks to patients.  
- Distinction from informed consent: a patient’s consent obligation and a physician’s duty to inform arise from medical practice; they are separate from the manufacturer’s duty to warn.

2) Step-by-step reasoning
- Kurdashian Inc., as the manufacturer of implants, possessed knowledge about material risks associated with the implant.  
- Under the learned intermediary doctrine, the proper channel for communicating those risks is the prescribing physician (Dr. Monebags), who assesses patient-specific risks and communicates them to the patient.  
- Therefore Kurdashian Inc. should ensure Dr. Monebags received full, accurate information about all known risks so he could advise the patient appropriately.

3) Intermediate logical steps
- Manufacturer knows risk → manufacturer must warn a foreseeable communicator → physician is the foreseeable communicator for prescription devices → warning the physician fulfills the duty to warn (unless exceptions apply, e.g., direct-to-consumer marketing or where no intermediary exists).

4) Why the correct answer is correct
The correct option explicitly states that Kurdashian Inc. should have ensured Dr. Monebags, as the learned intermediary, knew all risks the company knew and that he communicated those risks to the patient. That matches the learned intermediary doctrine and the manufacturer’s duty to warn in the medical-device context.

5) Why the other options are incorrect
- Option 1 confuses the manufacturer’s duty to warn with the patient’s duty to understand consent; informed consent is a clinical responsibility of the physician, not the manufacturer’s legal duty.  
- Option 2 falsely asserts manufacturers cannot communicate risks directly; manufacturers can and must communicate risks appropriately (to physicians via labeling, inserts, and to consumers in some settings), so saying the duty to warn is “not applicable” is incorrect.

6) Conclusion
Therefore, the correct answer is that Kurdashian Inc. should have ensured Dr. Monebags, as the learned intermediary, knew all of the risks that the company knew about the implants and that he communicated these risks to the patient, which matches the provided answer.

According to the duty to warn:单项选择题

类似问题

If it can be shown that, even knowing the risk of rupture with ordinary use of the implants, Kitty would have gone ahead and gotten the implants anyway:

In a negligence-based product liability case, the plaintiff must prove that the manufacturer breached its duty of care to the original purchaser only

A project has a required return of 12.6 percent, an initial cash outflow of $42,100, and cash inflows of $16,500 in Year 1, $11,700 in Year 2, and $10,400 in Year 4. What is the net present value?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单